An article in The Economist makes a case for Europe to get up to speed and embrace GMOs. In the 12 years that genetically modified organisms have been commercially available, both profits and areas under cultivation have grown. What the article doesn't fully address are the reasons that Europeans have pretty much refused to jump on the bandwagon.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.